151 related articles for article (PubMed ID: 26894578)
1. Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors.
de Veer SJ; Swedberg JE; Brattsand M; Clements JA; Harris JM
Biol Chem; 2016 Dec; 397(12):1237-1249. PubMed ID: 26894578
[TBL] [Abstract][Full Text] [Related]
2. Engineered protease inhibitors based on sunflower trypsin inhibitor-1 (SFTI-1) provide insights into the role of sequence and conformation in Laskowski mechanism inhibition.
de Veer SJ; Swedberg JE; Akcan M; Rosengren KJ; Brattsand M; Craik DJ; Harris JM
Biochem J; 2015 Jul; 469(2):243-53. PubMed ID: 25981970
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Kallikrein-Related Peptidases 7 and 5 by Grafting Serpin Reactive-Center Loop Sequences onto Sunflower Trypsin Inhibitor-1 (SFTI-1).
Jendrny C; Beck-Sickinger AG
Chembiochem; 2016 Apr; 17(8):719-26. PubMed ID: 26574674
[TBL] [Abstract][Full Text] [Related]
4. Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14.
de Veer SJ; Swedberg JE; Parker EA; Harris JM
Biol Chem; 2012 Apr; 393(5):331-41. PubMed ID: 22505516
[TBL] [Abstract][Full Text] [Related]
5. Engineering potent mesotrypsin inhibitors based on the plant-derived cyclic peptide, sunflower trypsin inhibitor-1.
de Veer SJ; Li CY; Swedberg JE; Schroeder CI; Craik DJ
Eur J Med Chem; 2018 Jul; 155():695-704. PubMed ID: 29936356
[TBL] [Abstract][Full Text] [Related]
6. Improving the Selectivity of Engineered Protease Inhibitors: Optimizing the P2 Prime Residue Using a Versatile Cyclic Peptide Library.
de Veer SJ; Wang CK; Harris JM; Craik DJ; Swedberg JE
J Med Chem; 2015 Oct; 58(20):8257-68. PubMed ID: 26393374
[TBL] [Abstract][Full Text] [Related]
7. Characterization of SPINK9, a KLK5-specific inhibitor expressed in palmo-plantar epidermis.
Brännström K; Ohman A; von Pawel Rammingen U; Olofsson A; Brattsand M
Biol Chem; 2012 Apr; 393(5):369-77. PubMed ID: 22505519
[TBL] [Abstract][Full Text] [Related]
8. Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.
de Veer SJ; Furio L; Swedberg JE; Munro CA; Brattsand M; Clements JA; Hovnanian A; Harris JM
J Invest Dermatol; 2017 Feb; 137(2):430-439. PubMed ID: 27697464
[TBL] [Abstract][Full Text] [Related]
9. Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold - A Potential Therapeutic Intervention for Skin Diseases.
Chen W; Kinsler VA; Macmillan D; Di WL
PLoS One; 2016; 11(11):e0166268. PubMed ID: 27824929
[TBL] [Abstract][Full Text] [Related]
10. KLK4 Inhibition by Cyclic and Acyclic Peptides: Structural and Dynamical Insights into Standard-Mechanism Protease Inhibitors.
Riley BT; Ilyichova O; de Veer SJ; Swedberg JE; Wilson E; Hoke DE; Harris JM; Buckle AM
Biochemistry; 2019 May; 58(21):2524-2533. PubMed ID: 31058493
[TBL] [Abstract][Full Text] [Related]
11. Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome.
White GV; Edgar EV; Holmes DS; Lewell XQ; Liddle J; Polyakova O; Smith KJ; Thorpe JH; Walker AL; Wang Y; Young RJ; Hovnanian A
Bioorg Med Chem Lett; 2019 Mar; 29(6):821-825. PubMed ID: 30691925
[TBL] [Abstract][Full Text] [Related]
12. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
Meyer-Hoffert U; Wu Z; Schröder JM
PLoS One; 2009; 4(2):e4372. PubMed ID: 19190773
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein-related peptidase 14 is the second KLK protease targeted by the serpin vaspin.
Ulbricht D; Tindall CA; Oertwig K; Hanke S; Sträter N; Heiker JT
Biol Chem; 2018 Sep; 399(9):1079-1084. PubMed ID: 29494334
[TBL] [Abstract][Full Text] [Related]
14. A Potent and Selective Kallikrein-5 Inhibitor Delivers High Pharmacological Activity in Skin from Patients with Netherton Syndrome.
Liddle J; Beneton V; Benson M; Bingham R; Bouillot A; Boullay AB; Brook E; Cryan J; Denis A; Edgar E; Ferrie A; Fouchet MH; Grillot D; Holmes DS; Howes A; Krysa G; Laroze A; Lennon M; McClure F; Moquette A; Nicodeme E; Santiago B; Santos L; Smith KJ; Thorpe JH; Thripp G; Trottet L; Walker AL; Ward SA; Wang Y; Wilson S; Pearce AC; Hovnanian A
J Invest Dermatol; 2021 Sep; 141(9):2272-2279. PubMed ID: 33744298
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based selection of a potent kallikrein-related peptidase 7 inhibitor from a versatile library based on the sunflower trypsin inhibitor SFTI-1.
de Veer SJ; Ukolova SS; Munro CA; Swedberg JE; Buckle AM; Harris JM
Biopolymers; 2013 Sep; 100(5):510-8. PubMed ID: 24078181
[TBL] [Abstract][Full Text] [Related]
16. Design of Potent and Selective Cathepsin G Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold.
Swedberg JE; Li CY; de Veer SJ; Wang CK; Craik DJ
J Med Chem; 2017 Jan; 60(2):658-667. PubMed ID: 28045523
[TBL] [Abstract][Full Text] [Related]
17. Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors.
Walker AL; Denis A; Bingham RP; Bouillot A; Edgar EV; Ferrie A; Holmes DS; Laroze A; Liddle J; Fouchet MH; Moquette A; Nassau P; Pearce AC; Polyakova O; Smith KJ; Thomas P; Thorpe JH; Trottet L; Wang Y; Hovnanian A
Bioorg Med Chem Lett; 2019 Oct; 29(20):126675. PubMed ID: 31521475
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.
Eissa A; Amodeo V; Smith CR; Diamandis EP
J Biol Chem; 2011 Jan; 286(1):687-706. PubMed ID: 20940292
[TBL] [Abstract][Full Text] [Related]
19. 3-Acyltetramic acids as a novel class of inhibitors for human kallikreins 5 and 7.
de Souza AS; Pacheco BDC; Pinheiro S; Muri EMF; Dias LRS; Lima CHS; Garrett R; de Moraes MBM; de Souza BEG; Puzer L
Bioorg Med Chem Lett; 2019 May; 29(9):1094-1098. PubMed ID: 30833107
[TBL] [Abstract][Full Text] [Related]
20. An unexpected switch in peptide binding mode: from simulation to substrate specificity.
Kahler U; Fuchs JE; Goettig P; Liedl KR
J Biomol Struct Dyn; 2018 Nov; 36(15):4072-4084. PubMed ID: 29210603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
